Abstract
Decreased acid secretion, due to therapy or disease, predisposes to increased bacterial counts in gastric juice. As bacterial numbers increase, the number of nitrate-reducing strains and the concentration of luminal nitrite usually also increase. However, there is controversy (mainly because of assay problems) about whether decreased acid increases generation ofN-nitroso compounds: these may be produced by acid or by bacterial catalysis, and the relative contributions of each are still uncertain. Other potentially important factors include ascorbate secretion (can prevent nitrite conversion to nitroso compounds) and the particular spectrum of nitroso compounds produced. Nitrosation of several histamine H2-receptor antagonists has been demonstrated experimentally, but under conditions that are very unlikely to be encountered clinically. Some acid suppressant therapies have been claimed to aid eradication ofHelicobacter pylori, but more work is needed to evaluate this. If ulcer treatment regimens do not also address eradication ofH. pylori (when present), gastritis will progress, and the recently documented association betweenH. pylori and gastric carcinoma needs to be considered. Enteric flora probably also increase if acid secretion is markedly reduced: this does not appear to have nutritional consequences but probably reduces the resistance to occasional infections, of which cholera is the best documented.
Similar content being viewed by others
References
Giraud AS, Yeomans ND, St John DJB: Ultrastructure and cytochemistry of the gastric mucosa of a reptile,Tiliqua scincoides. Cell Tissue Res 197:281–294, 1979
Giraud AS, Yeomans ND: Fine structure of the gastric mucosa of a toad,Bufo marinus. Cell Tissue Res 218:663–668, 1981
Giraud AS, Yeomans ND: Cell types of the gastric mucosa of a teleost: The river blackfish,Gadopsis marmoratis. Aust J Mar Freshwater Res 33:1103–1108, 1982
Rees W, Turnberg LA: Mechanisms of gastric mucosal protection; a role for the mucous bicarbonate barrier. Clin Sci 62:344–348, 1982
Henning N: Die bakterielle besiedlung des gesunden und des kranken Magens. Arch Verdaungskr 47:1–59, 1930
Drasar BS, Shiner M, McLeod GM: Studies on the intestinal flora. I. The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons. Gastroenterology 56:71–79, 1969
Franklin MA, Skoryna SC: Studies on natural gastric flora: I. Bacterial flora of fasting human subjects. Can Med Assoc J 95:1349–1355, 1966
Franklin MA, Skoryna SC: Studies on natural gastric flora: Survival of bacteria in fasting human subjects. Can Med Assoc J 105:380–386, 1971
Stockbrügger RW, Cotton PB, Menon GG, Beilby JOW, Bartholomew BA, Hill MJ, Walters CL: Pernicious anaemia, intragastric bacterial overgrowth, and possible consequences. Scand J Gastroenterol 19:355–364, 1984
Ruddell WS, Axon AT, Findlay JM, Bartholomew BA, Hill MJ. Effect of cimetidine on the gastric bacterial flora. Lancet 1:672–674, 1980
Thomas JM, Misiewicz JJ, Cook AR, Hill MJ, Smith PLR, Walters CL, Forster JL, Martin LE, Woodings DF: Effects of one year's treatment with ranitidine and of truncal vagotomy on gastric contents. Gut 28:726–738, 1987
Stockbrügger RW, Cotton PB, Eugenides N, Bartholomew BA, Hill M, Walters CL: Intragastric nitrites, nitrosamines, and bacterial overgrowth during cimetidine treatment. Gut 23:1048–1054, 1982
Milton-Thompson GJ, Lightfoot NF, Ahmet Z, Hunt RH, Barnard J, Bavin PMG, Brimblecombe RW, Darkin DW, Moore PJ, Viney N: Intragastric acidity, bacteria, nitrite and N-nitroso compounds before, during, and after Cimetidine treatment. Lancet 2:1091–1095, 1982
Leach SA, Hill MJ: The effects of sustained and profound inhibition of gastric acid production on gut flora. Res Clin Forums 12:139–152, 1990
Armbrecht U, Bosaeus I, Gillberg R, Seeberg S, Stockbrügger R: Hydrogen (H2) breath test and gastric bacteria in acid-secreting subjects and in achlorhydric and postgastrectomy patients before and after antimicrobial treatment. Scand J Gastroenterol 20:805–813, 1985
Hall CN, Darkin D, Brimblecombe R, Cook AJ, Kirkham J, Northfield TC: Evaluation of the nitrosamine hypothesis of gastric carcinogenesis in precancerous conditions. Gut 27:491–498, 1986
Gray JDA, Shiner M: Influence of gastric pH on gastric and jejunal flora. Gut 8:574–581, 1967
Schumpelick V, Schassan HH Bakteriologie des operierten Magens. Langenbecks Arch Chir 350:271–279, 1980
Drasar BS, Shiner M: Studies on the small intestinal flora. II. Bacterial flora of the small intestine in patients with gastrointestinal disorders. Gut 10:812–819, 1969
Muscroft TJ, Deane SA, Youngs D, Burdon DW, Keighley MR: The microflora of the postoperative stomach. Br J Surg 68:560–564, 1981
Keighley MRB, Youngs D, Poxon V, Morris D, Muscroft TJ, Burdon DW, Barnard J, Bavin PMG, Brimblecombe RW, Darkin DW, Moore PJ, Viney N: IntragastricN-nitrosation is unlikely to be responsible for gastric carcinoma developing after operations for duodenal ulcer. Gut 25:238–245, 1984
Kyrtopoulos SA, Daskalakis G, Legakis NI, Konidaris N, Psarrou E, Bonatsos G, Golematis B, Lakisotis G, Bliouras N, Outram JR: Studies in gastric carcinogenesis. ii. Absence of elevated concentrations ofN-nitroso compounds in the gastric juice of Greek hypochlorhydric individuals. Carcinogenesis 6:1135–1140, 1985
Broido PW, Gorbach SL, Condon RE, Nyhus LM: Upper intestinal microfloral control. Arch Surg 106:90–93, 1973
Stockbrügger RW: Bacterial overgrowth as a consequence of reduced gastric acidity. Scand J Gastroenterol 111(suppl):7–16, 1985
Rogers MJ, Holmfield HJM, Primrose JN, Gledhill T, Johnston D: A prospective comparison of the effects of placebo, ranitidine and highly selective vagotomy on 24 h ambulatory intragastric pH in patients with duodenal ulcer. Br J Surg 75:961–965, 1988
Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M: A model for gastric cancer epidemiology. Lancet 2:58–60, 1975
Kyrtopoulos SA, Daskalakis G, Outram JR: Studies in gastric carcinogenesis. iii. The kinetics of nitrosation of gastric-juice componentsin vitro and their implications for thein vivo formation ofN-nitroso compounds in normal and in hypochlorhydric populations. Carcinogenesis 6:1141–1145, 1985
Snepar R, Poporad GA, Romano JM, Kobasa WD, Kaye D: Effect of cimetidine and antacid on gastric microbial flora. Infect Immun 36:518–524, 1982
O'Connor HJ, Riley SE, Axon AT, Garner RC: Effect of histamine H2-receptor antagonist therapy on the mutagenic activity of gastric juice. Mutat Res 188:201–208, 1987
Sharma BK, Santana IA, Wood EC, Walt RP, Perieira M, Noane P, Smith PLR, Walters CL, Pounder RE: Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. BMJ 289:717–719, 1984
Rowland JR: The toxicology ofN-nitroso compounds.In Nitrosamines—Toxicology and Microbiology. Hill MJ (ed). London, England, Ellis Horwood, 1988, pp 117–141
Fine DH: Analytical methods for nitrosamines—an overview.In Nitrosamines in Human Cancer (Banbury Report 12). Magee PN (ed). Cold Spring Harbor, New York, Cold Spring Harbor Laboratory, 1982, pp 165–174
Simenhoff ML, Dunn SR, Kirkwood GR, Fiddler W, Pensabene JW: Presence of nitrosamines in blood of normal and diseased human stomach.In Nitrosamines in Human Cancer (Banbury Report 12). Magee PN (ed). Cold Springer Harbor, New York, Cold Spring Harbor Laboratory, 1982, pp 283–293
Fine DH, Challis BC, Hartman P, Van Ryzin J: Endogenous synthesis of volatile nitrosamines: Model calculations and risk factors. IARC Sci Publ 42:379–396, 1982
Mende P, Spigelhalder B, Preussman R: Trace analysis of nitrosated food stuffs for nitrosamides. Food Chem Toxicol 29:167–172, 1991
Walters CL, Downes MJ, Edwards MW, Smith PLR: Determination of a non-volatileN-nitrosamine on a food matrix. Analyst 103:1127–1133, 1978
Eisenbrand G, Janzowski C, Pruessmann R: Analytical method forN-nitroso compounds. J Chromatogr 115:602–605, 1975
Bavin PM, Darkin DW, Viney NJ: Total nitroso compounds in gastric juice. IARC Sci Publ 41:337–344, 1982
Smith PRL, Walters CL, Reed PI: The importance of selectivity in the determination ofN-nitroso compounds as a group. Analyst 108:896–898, 1983
Pignatelli B, Richard I, Bourgade MC, Bartsch H: An improved method for analysis of totalN-nitroso compounds in gastric juice. IARC Sci Publ 84:209–215, 1987
Oshima H, Bartsch H: Quantitative estimation of endogenous nitrosation in humans by monitoringN-nitrosoproline excreted in the urine. Cancer Res 41:3658–3662, 1981
Mirvish S, Bulay O, Runge RG, Patil K: Study of the carcinogenicity of large doses of dimethylnitramine,N-nitroso-l-proline, and sodium nitrite administered in drinking water to rat. J Natl Cancer Inst 64:1435–1442, 1980.
Dailey RE, Braunberg RC, Blaschka AM: The absorption, distribution and excretion of [14C]-nitrosoproline by rats. Toxicology 3:23–28, 1975
Houghton PW, Leach S, Owen RW, McC Mortensen NJ, Hill M, Williamson RC: Use of a modifiedN-nitrosoproline test to show intragastric nitrosation in patients at risk of gastric cancer. Br J Cancer 60:231–234, 1989
Mirvish SS: Kinetics ofN-nitrosation in relation to tumourigenesis experiments with nitrite plus amines or urea. IARC Sci Publ 3:104–108, 1972
Sander J, Schweinsburg F, Menz HP: Untersuchunger uber die Entstehung cancerogener Nitrosamine in Magen. Z Physiol Chem 349:1691–1697, 1968
Hawksworth GM, Hill MJ: Bacteria andN-nitrosation of secondary amines. Br J Cancer 25:520–526, 1971
Leach S, Cook A, Challis A, Hill MJ, Thompson M: A model describing the role of bacteria and N-nitroso compounds in gastric carcinogenesis. Cancer Lett 30(suppl):S27-S28, 1986
Calmels S, Bereziat JC, Ohshima H, Bartsch H: Bacterial formation ofN-nitroso compounds from administered precursors in the rat stomach after omeprazole-induced achlorhydria. Carcinogenesis 12:435–439, 1991
Rathbone BJ, Johnson AW, Wyatt JI, Kelleher J, Heatley RV, Losowsky MS: Ascorbic acid: A factor concentrated in human gastric juice. Clin Sci 76:237–241, 1989
Walters CL: Vitamin C and nitrosamine formation.In Vitamin C. Recent Aspects of its Physiology and Technical Importance. Birch GG, Parker K (eds). London, Academic Press, 1974
Kamm JJ, Dashman T, Conney AH, Burns JJ: Effect of ascorbic acid on amine-nitrate toxicity. Ann NY Acad Sci 258:169–174, 1975
Lijinsky W, Greenblatt M: Dimethyl-nitrosamine producedin vivo from nitrite and aminopyrine. Nature (London) New Biol 236:177–178, 1972
Risch HA, Jain M, Choi NW, Fodor JG, Pfeiffer CJ, Howe GR, Harrison LW, Craib KJP, Miller AB: Dietary factors and the incidence of cancer of the stomach. Am J Epidemiol 122:947–959, 1985
Sobala GM, Schorah CJ, Sanderson M, Dixon MF, Tompkins DS, Godwin P, Axon ATR: Ascorbic acid in the human stomach. Gastroenterology 97:357–363, 1989
Sobala GM, Pignatelli B, Schorah CJ, Bartsch H, Sanderson M, Dixon MF, Shires S, King RFG, Axon ATR: Levels of nitrite, nitrate,N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach. Carcinogenesis 12:193–198, 1991
Licht WR, Tannenbaum SR, Deen WM: Use of ascorbic acid to inhibit nitrosation: Kinetic and mass transfer considerations for anin vitro system. Carcinogenesis 9:365–372, 1988
Licht WR, Deen WM: Theoretical model for predicting rates of nitrosamine and nitrosamide formation in the human stomach. Carcinogenesis 9:2227–2237, 1988
Bartsch H, Ohshima H, Pignatelli B: Inhibitors of endogenous nitrosation. Mechanisms and implications in human cancer prevention. Mutat Res 202:307–324, 1988
Reed PI, Smith PL, Haines K, House FR, Walters CL: Effect of cimetidine on gastric juiceN-nitrosamine concentration. Lancet 2:553–556, 1981
Reed PI, Summers K, Smith PLR, Walters CL, Bartholomew BA, Hill MJ, Veritt S, House FR, Hornig DH, Bonjour J-P: Effect of gastric surgery for benign peptic ulcer and ascorbic acid therapy on concentrations of nitrite andN-nitroso compounds in gastric juice. IARC Sci Publ 57:975–979, 1984
Elder JB, Burdett K, Smith PL, Walters CL, Reed PI: Effect of H2 blockers on intragastric nitrosation as measured by 24-hour urinary secretion ofN-nitrosoproline. IARC Sci Publ 57:969–974, 1984
Hall CN, Kirkham JS, Northfield TC: UrinaryN-nitrosoproline excretion: A further evaluation of the nitrosamine hypothesis of gastric carcinogenesis in precancerous conditions. Gut 28:216–220, 1987
Elder JB, Ganguli PC, Koffman CG, Wells S, Williams G: Possible role of cimetidine and its nitrosation products in stomach cancer.In Nitrosamines in Human Cancer (Banbury Report 12). Magee PN (ed). Cold Springer Harbor, New York, Cold Spring Harbor Laboratory, 1982, pp 335–349
De Flora S, Bennicelli C, Camoirano A, Zanacchi P: Genotoxicity of nitrosated ranitidine. Carcinogenesis 4:255–260, 1983
De Flora S, Camoirano A, Basso C, Astegno M, Zanacchi P, Bennicelli C: Bacterial genotoxicity of nitrosated famotidine. Mutagenesis 1:125–130, 1986
Franekic J, Skupnjak S, Matijasevic Z: Genotoxicity of nitrosated ranitidine. Mutat Res 227:13–16, 1989
Martelli A, Fugassa E, Voci A, Brambilla G: Unscheduled DNA synthesis induced by nitrosated ranitidine in primary cultures of rat hepatocytes. Mutat Res 122:373–376, 1983
Brambilla G, Cavanna M, Faggin P, Maura A, Pino A, Ricci R, Robbiano L: Genotoxic effects in rodents given high oral doses of ranitidine and sodium nitrite. Carcinogenesis 4:1281–1285, 1983
Brambilla G, Cavanna M, Maura A, Pino A, Robbiano L, Carlo P, Biassoni F, Ricci R: Absence of DNA damage in liver of rats given high doses of cimetidine and sodium nitrite. J Pharmacol Exp Ther 221:222–227, 1982
Morris DL, Young D, Muscroft TJ, Burdon DW, Keighley MR: Mutagenicity in gastric juice. Gut 25:723–727, 1984
De Flora S, Picciotto A, Savarino V, Bennicelli C, Camoirano A, Garibotto G, Celle G: Circadian monitoring of gastric juice mutagenicity. Mutagenesis 2:115–119, 1987
Habs M, Eisenbrand G, Habs H, Schmahl D: No evidence of carcinogenicity of N-nitrosocimetidine in rats. Hepatogastroenterology 29:265–266, 1982
Anderson LM, Giner Sorolla A, Haller IM, Budinger JM: Effects of cimetidine, nitrite, cimetidine plus nitrite, and nitrosocimetidine on tumors in mice following transplacental plus chronic lifetime exposure. Cancer Res 45:3561–3566, 1985
Leslie GB, Noakes DN, Pollitt FD, Row FJC, Walker TF: A two year study with cimetidine in the rat; assessment for chronic toxicity and carcinogenicity. Toxicol Appl Pharmacol 61:119–137, 1981
Coghlan JG, Gilligan D, Humphreys H, McKenna D, Sweeney E, Keane C, O'Morain C: Efficacy of different dosage regimes in duodenal ulcer healing and eradication ofCampylobacter pylori. Gut 28:A1409, 1987
O'Morain C, Coghlan G, Tobin A, Casey E, Hutchinson L, Gilligan D, McKenna D, Sweeney E, Keane C: Adjuvant antibiotic therapy and colloidal bismuth subcitrate in duodenal ulcer healing and the eradication ofCampylobacter pylori. Gastroenterology 94:A334, 1988
Berstad A, Alexander B, Weberg R, Serck-Hanssen A, Holland S, Hirschowitz BI: Antacids reduceCampylobacter pylori colonization without healing the gastritis in patients with non ulcer dyspepsia and erosive prepyloric changes. Gastroenterology 95:619–624, 1988
Hirschl AM, Hentschel E, Schutze K, Nemec H, Pötzi, Gangl A, Weiss W, Pletschette M, Stanek G, Rotter ML: The efficacy of antimicrobial treatment inCampylobacter pylori-associated gastritis and duodenal ulcer. Scand J Gastroenterol 23(suppl 142):76–81, 1988
McIntyre RLE, Piris J, Truelove SC: Effect of cimetidine on chronic gastritis in gastric ulcer patients. Aus NZ J Med 12:106, 1982 (abstract)
Rauws EAJ, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GNJ:Campylobacter pyloridis-associated chronic active antral gastritis. Gastroenterology 94:33–40, 1988
Paradis A, Goldie J, Veldhuyzen van Zanten SJO, Richardson, H, Hunt RH: Thein vitro inhibitory effect of omeprazole onHelicobacter pylori: A biochemical distribution? Enferm Dig P207, 1990 (abstract)
Mégraud F, Brassens-Rabbé M-P, Denis F, Belbouri A, Hoa DQ: Seroepidemiology ofCampylobacter pylori infection in various populations. J Clin Microbiol 27:1870–1873, 1989
Unge P, Gad A, Gnarpe H, Olsson J: Does omeprazole improve antimicrobial therapy directed towards gastricCampylobacter pylori in patients with antral gastritis? A pilot study. Scand J Gastroenterol 167(suppl):49–54, 1989
Mainguet P, Delmee M, Debongnie JC: Omeprazole,Campylobacter pylori and duodenal ulcer. Lancet 2:389–390, 1989
Catalano F, Mangiamoli A, Brogna A:Campylobacter pylori and duodenal ulcer disease: Effects of acute treatment of omeprazole versus ranitidine. Z Gastroenterol 27:159–160, 1990
Biasco G, Miglioli M, Barbara L, Corinaldesi R, Di Febo G: Omeprazole,Helicobacter pylori, gastritis and duodenal ulcer. Lancet 2:1403, 1989
Rauws EAJ, Langenberg W, Bosna A, Dankert J, Tytgat GNJ: Lack of eradication ofHelicobacter pylori after omeprazole. Lancet 337:1093, 1991
Weil J, Bell GD, Powell K, Morden A, Harrison G, Gant PW, Jones PH, Trowell JE: Omeprazole andHelicobacter pylori: Temporary suppression rather than true eradication. Aliment Pharmacol Ther 5:309–313, 1991
Labenz J, Gyenes E, Ruhl GH, Börsch G: Amoxicillinomeprazole treatment for eradication ofHelicobacter pylori. Enferm Dig P204, 1990 (abstract)
Unge P, Gad A, Eriksson K, Bergman B, Carling L, Ekström P, Glise H, Gnarpe H, Junghard O, Lindholmer C, Sandzén B, Strandberg L, Stubberöd A, Weywardt L: Amoxycillin added to omeprazole prevents relapse in the treatment of duodenal ulcer patients. Eur J Gastroenterol Hepatol 5:325–331, 1993
Lamouliatte H, Megraud F, de Maccaral A: Does omeprazole improve amoxicillin therapy directed towardsC. pylori associated chronic gastritis? Klin Wochenschr 67:(suppl 17):37 1989
Westblom TU, Duriex DE: H2 blockers increase antibiotic concentrations in gastric mucosa. Enferm Dig P262, 1990 (abstract)
O'Connor HJ, Dixon MF, Wyatt JI, Axon ATR, Ward DC, Dewar EP, Johnston D: Effect of duodenal ulcer surgery and enterogastric reflux onCampylobacter pyloridis. Lancet 2:1178–1181, 1986
Yeomans ND: Bacteria in ulcer pathogenesis.In Piper DW (ed). Peptic ulceration. Baillières Clin Gastroenterol 2:573–591, 1988
Marshall BJ, Warren RJ: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1:1311–1315, 1984
Dooley CP, Cohan H, Fitzgibbons PL, Bauer M, Appleman MD, Perez-Perez GI, Blaser MJ: Prevalence ofHelicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 321:1562–1566, 1989
Price AB, Levi J, Dolby JM, Dunscombe PL, Smith, A, Clark J, Stephenson ML:Campylobacter pyloridis in peptic ulcer disease: microbiology, pathology and scanning electron microscopy. Gut 26:1183–1188, 1985
Wyatt JJ, Rathbone BJ, Heatley RV: Local immune response to gastricCampylobacter in non-ulcer dyspepsia. J Clin Pathol 39:863–870, 1986
Wyatt JJ, Rathbone BJ, Dixon MF, Heatley RV:Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol 40:841–848, 1987
Blaser MJ:Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 161:626–633, 1990
Blaser MJ: GastricCampylobacter-like organisms, gastritis and peptic ulcer disease. Gastroenterology 93:371–383, 1987
Drumm B, Perez-Perez GI, Blaser MJ, Sherman PM: Intrafamilial clustering ofHelicobacter pylori infection. N Engl J Med 322:359–363, 1990
Klein BD, Gastrointestinal Physiology Working Group, Graham DY, Gaillour A, Opekun AR, O'Brian Smith E: Water source as risk factor forHelicobacter pylori infection. N Engl J Med 322:359–363, 1990
Graham DY, Alpert LC, Smith JL, Yoshimura HH: IatrogenicCampylobacter pylori infection is a cause of epidemic achlorhydria. Am J Gastroenterol 83:974–980, 1988
Harford W, Barnett E, Lee E, Cohen R, Mertz H, Walsh J, Peterson W: Epidemic gastritis with hypochlorhydria: 10-year follow up. Gastroenterology 100:A79, 1991
Meyer B, Werth B, Beglinger C, Dill S, Drewa J, Vischer WA, Eggers RH, Bauer FE, Stalder GA:Helicobacter pylori infection in healthy people, a dynamic process? Gut 32:347–350, 1991
Levi S, Beardshall K, Desa LA, Calam J:Campylobacter pylori, gastrin, acid secretion and duodenal ulcers. Lancet 2:613, 1989
Smith JTL, Pounder RE, Nwokolo CU, Lanzon-Miller S, Evans DG, Graham DY, Evans DJ Jr: Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected withHelicobacter pylori. Gut 31:522–525, 1990
Peterson W, Barnett C, Evans DJ Jr, Feldman M, Richardson C, Walsh J, Graham D: Role ofH. pylori in gastric acid secretion and serum concentrations in healthy subjects and patients with duodenal ulcers. Gastroenterology 100:A140, 1991
Graham DY:Campylobacter pylori and peptic ulcer disease. Gastroenterology 96:615–625, 1989
Correa P, Fox J, Fontham E, Ruiz B, Lin Y, Zavala D, Taylor N Mackinley D, de Lima E, Portilla H, Zarama G:Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer 66:2569–2574, 1990
Jaskiewicz K, Louwrens HD, Woodroof CW, Van Wyk MJ, Price SK: The association ofCampylobacter pylori with mucosal pathological changes in a population at risk of gastric cancer. S Afr Med J 75:417–419, 1989
Fox JG, Correa P, Taylor NS, Zavala D, Fontham E, Janney F, Rodriguez E, Hunter F, Diavolitis S:Campylobacter pylori-associated gastritis and immune response in a population at increased risk of gastric carcinoma. Am J Gastroenterol 84:775–781, 1989
Feng YY, Wang Y.Campylobacter pylori in patients with gastritis, peptic ulcer, and carcinoma of the stomach in Lanzhou, China. Lancet 1:1055, 1988
Jiang SJ, Liu WZ, Zhang DZ, Shi Y, Xiao D, Zhang ZH, Lu DY.Campylobacter-like organisms in chronic gastritis, peptic ulcer, and gastric carcinoma. Scand J Gastroenterol 22:553–558, 1987
Robey-Cafferty SS, Ro JY, Cleary KK: The prevalence ofCampylobacter pylori in gastric biopsies from cancer patients. Mod Pathol 2:473–476, 1989
Barker DJP, Coggon D, Osmond C, Wickham C: Poor housing in childhood and high rates of stomach cancer in England and Wales. Br J Cancer 61:575–578, 1990
Sedgwick DM, Akoh JA, MacIntyre IMC: Gastric cancer in Scotland: Changing epidemiology, unchanging workload. BMJ 302:1305–1307, 1991
Forman D, Newell DG, Fullerton F, Yarnell JWG, Stacey AR, Wald N, Sitas F: Association between infection withHelicobacter pylori and risk of gastric cancer evidence from a prospective investigation. BMJ 302:1302–1305, 1991
Forman D, Sitas F, Newell DG, Stacey AR, Boreham J, Peto R, Campbell TC, Li J, Chen J: Geographic association ofHelicobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int J Cancer 46:608–611, 1990
Nomura A, Stemmerman GN, Chyou P-H, Kato I, Perez-Perez GI, Blaser MJ:Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 325:1132–1136, 1991
Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK:Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127–1131, 1991
Talley NJ, Zinsmeister AR, Weaver A, DiMagno EP, Carpenter HA, Perez-Perez GI, Blaser MJ: Gastric adenocarcinoma andHelicobacter pylori infection. J Natl Cancer Inst 83:1734–1739, 1991
Forman D:Helicobacter pylori infection: A novel risk factor in the etiology of gastric cancer. J Natl Cancer Inst 83:1702–1703, 1991
Correa P: Is gastric carcinoma an infectious disease. N Engl J Med 325:1170–1171, 1991
Elder JB, Knight T: Surgical suppression of gastric acid secretion: lessons from long term follow-up studies. Scand J Gastroenterol 26(suppl 188):26–32, 1991
Caygill CPJ, Hill MJ, Hall CN, Kirkham JS, Northfield TC: Increased risk of cancer at multiple sites after gastric surgery for peptic ulcer. Gut 28:924–928, 1987
Borch K: Atrophic gastritis and gastric carcinoid tumours. Ann Med 21:291–297, 1989
Brinton LA, Gridley G, Hrubec Z, Hoover R, Fraumeni JF Jr: Cancer risk following pernicious anaemia. Br J Cancer 59:810–813, 1989
King CE, Toskes PP: Small intestine bacterial overgrowth. Gastroenterology 76:1035–1055, 1979
Greenlee HB, Vivit R, Paez J, Dietz A: Bacterial flora of the jejunum following peptic ulcer surgery. Arch Surg 102:260–265, 1971
Browning GG, Buchan KA, Mackay C: The effect of vagotomy and drainage on the small bowel flora. Gut 15:139–142, 1974
Pollak R, Varkonyi T, Nagy E, Varro V: Gastric acidity: An important factor regulating the composition of the bacterial flora in the small intestine. Acta Med Hung 43:365–368, 1986
Ruddell WS, Losowsky MS: Severe diarrhoea due to small intestinal colonisation during cimetidine treatment. BMJ 281:273, 1980
Gurian L, Ward TT, Katon RM: Possible foodborne transmission in a case of pseudomembranous colitis due toClostridium difficile: Influence of gastrointestinal secretions onClostridium difficile infection. Gastroenterology 83:465–469, 1982
Sack RB, Carpenter CCJ: Experimental canine cholera. I. Development of the model. J Infect Dis 119:138–149, 1969
Gitelson S: Gastrectomy, achlorhydria and cholera. Isr J Med Sci 7:663–667, 1971
Nalin DR, Levine RJ, Levine MM, Hoover D, Bergquist E, McLaughlin J, Libonati J, Alam J, Hornick RB: Cholera, non-Vibrio cholera, and stomach acid. Lancet 2:856–859, 1978
Nalin DR, Levine MM, Rhead J, Bergquist E, Rennels M, Hughes T, O'Donnell S, Hornick RB:Cannabis, hypochlorhydria and cholera. Lancet 2:859–862, 1978
Giannella RA, Broitman SA, Zamcheck N:Salmonella enteritis. I. Role of reduced gastric secretion in pathogenesis. Am J Dig Dis 16:1000–1006, 1971
Holt P: SevereSalmonella infection in patients with reduced gastric acidity. Practitioner 229:1027–1030, 1985
Buchin PJ, Andriole VT, Spiro HM:Salmonella infections and hypochlorhydria. J Clin Gastroenterol 2:133–138, 1980
Gray JA, Trueman AM: SevereSalmonella gastroenteritis associated with hypochlorhydria. Scott Med J 16:255–258, 1971
Slonin JM, Ireton HJ, Smallwood RA: Giardiasis following gastric surgery. Aust NZ J Med 6:479–480, 1976
Giannella RA, Broitman SA, Zamcheck N: Influence of gastric acidity on bacterial and parasitic enteric infections. A perspective. Ann Intern Med 78:271–276, 1973
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yeomans, N.D., Brimblecombe, R.W., Elder, J. et al. Effects of acid suppression on microbial flora of upper gut. Digest Dis Sci 40 (Suppl 2), 81S–95S (1995). https://doi.org/10.1007/BF02214873
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02214873